EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Assessing disease progression in spinal muscular atrophy, current gaps, and opportunities: a narrative review

R Muni-Lofra, G Coratti, T Duong, J Medina-Cantillo, M Civitello, A Mayhew, R Finkel, E Mercuri, C Marini-Bettolo, F Muntoni

Neuromuscular Disorders · 2025-04 · 49 · 105341

DOI: 10.1016/j.nmd.2025.105341 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuromuscular Disorders, 2025-04. Verfasst von R Muni-Lofra und 9 weiteren Autor:innen. Beteiligte Einrichtung: The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS F…. Hauptthemen laut MEDLINE: Disease Progression, Muscular Atrophy, Spinal, Outcome Assessment, Health Care. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal Muscular Atrophy is a genetic disorder causing muscle atrophy and progressive weakness. People living with the condition can have a significant heterogenous phenotype ranging from arrest of motor development to mild impairment. Assessing disease severity has been done using a range of outcome measures that can be classified by body structure or function, by activities or by participation. Functional outocome measures can be generic measures, used to compare individuals or populations against general norms, or disease-specific measures designed to fit disease characteristics. Outcome measures assessing participation are primarily used to capture patients' perceptions of health-related quality of life, daily activity abilities, caregiver burden, and the impact of physical symptoms like fatigue or pain. When assessing disease progression, often the focus on functional abilities has served as an overall indicator of change. With the appearance of disease modifying therapies and the need to evaluate the impact that they had in the course of the disease, new requirements for the existing assessments measure had appeared. The current available toolkit is able to capture a significant spectrum of both, natural history and effect of new treatments but the increased survival, changes in fatigue, bulbar function and others will benefit from further assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease ProgressionMuscular Atrophy, SpinalOutcome Assessment, Health CareHumansQuality of LifeSeverity of Illness IndexActivities of Daily Living

Stichwörter der Autor:innen

Disease modifying therapiesDisease progressionOutcome measuresSpinal muscular atrophy

Autor:innen und Institutionen

  • The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 3BZ, UK. Electronic address:…
  • Pediatric Neurology Unit, Catholic University of Sacred Heart, 00135 Rome, Italy; Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
  • Department of Neurology, Stanford University, Stanford, CA, United States.
  • Neuromuscular Unit, Rehabilitation Department, Hospital Universitari Sant Joan de Deu, Barcelona, Spain.
  • Center for Experimental Neurotherapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 3BZ, UK.

Zitieren

APA

Muni-Lofra, R., Coratti, G., Duong, T., Medina-Cantillo, J., Civitello, M., Mayhew, A., Finkel, R., Mercuri, E., Marini-Bettolo, C., & Muntoni, F. (2025). Assessing disease progression in spinal muscular atrophy, current gaps, and opportunities: a narrative review. Neuromuscular Disorders, 49, 105341. https://doi.org/10.1016/j.nmd.2025.105341

Vancouver

Muni-Lofra R, Coratti G, Duong T, Medina-Cantillo J, Civitello M, Mayhew A, et al. Assessing disease progression in spinal muscular atrophy, current gaps, and opportunities: a narrative review. Neuromuscular Disorders. 2025;49:105341. doi:10.1016/j.nmd.2025.105341

BibTeX
@article{MuniLofra2025,
  author = {Muni-Lofra, R and Coratti, G and Duong, T and Medina-Cantillo, J and Civitello, M and Mayhew, A and Finkel, R and Mercuri, E and Marini-Bettolo, C and Muntoni, F},
  title = {Assessing disease progression in spinal muscular atrophy, current gaps, and opportunities: a narrative review},
  journal = {Neuromuscular Disorders},
  year = {2025},
  volume = {49},
  pages = {105341},
  doi = {10.1016/j.nmd.2025.105341}
}
Kostenlos starten →